Preetesh Jain

Dr. Preetesh Jain is an Assistant Professor in the Department of Lymphoma/Myeloma within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX. He holds an MBBS, MD, DM, and PhD, with clinical training completed in both India and the United States. His PhD research at the Feinstein Institute for Medical Research focused on the 'Th17-IL-17 axis in CLL'. Dr. Jain joined MD Anderson in 2020 after additional training at the University of Texas-Houston and MD Anderson Cancer Center since 2012.

Dr. Jain specializes in translational research and clinical investigation of mantle cell lymphoma (MCL). He collaborates with Dr. Wang in the Mantle Cell Lymphoma group and serves as principal investigator for the Phase III randomized MANGROVE clinical trial in MCL. His research integrates molecular mechanisms with therapeutic development for hematologic malignancies.

Honors include multiple research awards in lymphoma/leukemia, invitations to speak at international conferences, and peer review activities for leading journals. His publication record in high-impact journals reflects an H-index of 35.